Summary | p. 1 |
Introduction | p. 23 |
Overview and Themes of the Report | p. 27 |
Historical and Policy Context | p. 33 |
Organization of Report | p. 43 |
Principles for Identifying and Assessing Conflicts of Interest | p. 44 |
What Is a Conflict of Interest? | p. 45 |
What Are the Purpose of Conflict of Interest Policies? | p. 48 |
Why Not Examine the Motives of the Decision Maker or the Validity of the Decision? | p. 50 |
Should Policies Also Require That Professionals Avoid the ôAppearance of Conflict of Interestö? | p. 52 |
How Can Conflicts of Interest Be Assessed? | p. 52 |
How Can Conflict of Interest Policies Be Evaluated? | p. 56 |
Conclusion | p. 60 |
Policies on Conflict of Interest: Overview and Evidence | p. 62 |
Overview of Conflict of Interest Policies | p. 64 |
Disclosure: An Essential but Insufficient Element of Policy | p. 67 |
Prohibiting or Eliminating Conflicts of Interest | p. 79 |
Evaluating and Managing Conflicts of Interest | p. 80 |
Recommendations | p. 87 |
Conflicts of Interest in Biomedical Research | p. 97 |
Collaboration and Discovery in Biomedicine | p. 98 |
Industry Funding and Relationships in Biomedical Research | p. 101 |
Concerns About Relationships with Industry | p. 102 |
Responses to Concerns About Conflicts of Interest in Research | p. 110 |
Recommendations | p. 116 |
Conflicts of Interest in Medical Education | p. 122 |
Background and COntext | p. 124 |
Learning Environments in Medical Schools and Residency Programs | p. 127 |
The Learning Environment in Accredited Continuing Medical Education | p. 140 |
Ghostwriting, Speakers Bureaus, and Independence of Publications and Presentations | p. 153 |
Recommendations | p. 157 |
Conflicts of Interest and Medical Practice | p. 166 |
The Broader Context: Physician Payment, Self-Referral, and Conflicts of Interest in Medical Practice | p. 167 |
Industry Promotional Activities and Practicing Physicians | p. 170 |
Responses to Concerns About Industry Relationships and Conflicts of Interest in Community Practice | p. 175 |
Recommendations | p. 183 |
Conflicts of Interest and Development of Clinical Practice Guidelines | p. 189 |
Background and Context | p. 190 |
Groups That Develop Clinical Practice Guidelines | p. 196 |
Financial Relationships in Guideline Development | p. 198 |
Policies on Conflicts of Interest in Clinical Practice Guideline Development | p. 204 |
Recommendations | p. 210 |
Institutional Conflicts of Interest | p. 216 |
What Are Institutional Conflicts of Interest? | p. 218 |
Extent of Institutional Relationships with Industry | p. 219 |
Responses to Institutional Conflicts of Interest | p. 221 |
Special Challenges in Managing Institutional Conflicts of Interest | p. 224 |
Recommendations | p. 226 |
Role of Supporting Organizations | |
How Supporting Organizations Can Influence Medical Institutions | p. 232 |
Recommendations | p. 235 |
References | p. 240 |
Appendixes | |
Study Activities | p. 285 |
U.S. Public Health Service Regulations: Objectivity in Research (42 CFR 50) | p. 295 |
Conflict of Interest in Four Professions: A Comparative Analysis | p. 302 |
How Psychological Research Can Inform Policies for Dealing with Conflicts of Interest in Medicine | p. 358 |
The Pathway from Idea to Regulatory Approval: Examples for Drug Development | p. 375 |
Model for Broader Disclosure | p. 384 |
Committee Biographies | p. 392 |
Index | p. 401 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.